Deltaretrovirus
-
Subject Areas on Research
- 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
- A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1.
- Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.
- Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.
- C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.
- Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.
- Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
- Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
- Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959.
- Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.
- Human T-cell leukemia/lymphoma virus: studies of host-virus interaction.
- Human T-cell lymphotropic virus I and adult T-cell leukemia: report of a cluster in North Carolina.
- Infection of the HTLV-II-bearing T-cell line C3 with HTLV-III/LAV is highly permissive and lytic.
- Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.
- Monoclonal antibodies against human T cell leukemia-lymphoma virus (HTLV) p24 internal core protein. Use as diagnostic probes and cellular localization of HTLV.
- Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.
- Persistent coinfection of T lymphocytes with HTLV-II and HIV and the role of syncytium formation in HIV-induced cytopathic effect.
- Phenotypic characterization and ontogeny of components of the human thymic microenvironment.
- Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.
- Prospects for treatment of human retrovirus-associated diseases.
- Retroviruses and human cancer: evaluation of T-lymphocyte transformation by human T-cell leukemia-lymphoma virus.
- Toward a vaccine against AIDS: rationale and current progress.
-
Keywords of People
- Cianciolo, George James, Associate Professor Emeritus of Pathology, Pathology
- Weinhold, Kent James, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Integrative Immunobiology